Latest Regulation News

Page 10 of 166
Metro Mining increased third-quarter shipments by 17% from the previous quarter and secured 4.5 million wet metric tonnes a year of binding offtake for 2027 to 2029. The result came with lower guidance, elevated costs and operational disruptions still weighing on the business.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Control Bionics has begun converting its expanded product and regulatory pipeline into revenue, while a completed $9.75 million capital raising gives the company a larger cash buffer. The next test is whether partner-led sales and NeuroStrip trial conversions can reduce its cash burn as planned.
Victor Sage
Victor Sage
29 Oct 2026
Buru Energy has booked 15.25 million boe of 2P reserves for its Rafael gas and condensate project, while advancing environmental and production approvals. The company has $2.5 million in cash, no debt and only 1.24 quarters of estimated funding at its reported expenditure rate, making the next financing a critical step.
Maxwell Dee
Maxwell Dee
29 Oct 2026
VRX Silica has completed the Arramall farm purchase and secured a 21-year lease for Arrowsmith North’s proposed processing plant, but final regulatory approvals and project financing remain outstanding. The company ended September with A$4.364 million in cash while estimating Arrowsmith North’s capital requirement at approximately A$74.5 million.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Siren Gold has applied to reclaim the Sams Creek ground, advanced permit and access applications across New Zealand, and raised A$799,000 by selling part of its RUA Gold stake. The progress comes with only A$596,000 in cash at quarter end, leaving the company reliant on project approvals and potential further funding options.
Maxwell Dee
Maxwell Dee
29 Oct 2026
The Australian Takeovers Panel has declared unacceptable circumstances in A2MP Investments’ lapsed A$0.05-a-share takeover bid for Canyon Resources, citing inadequate disclosure, the use of confidential information and potential coercion of shareholders. Final orders remain undecided.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Peppermint Innovation’s Philippine payments business delivered a sharp September-quarter acceleration, with customer receipts rising to A$1.18 million and operating cash outflow falling 55%. The company says early October volumes have already exceeded September’s full-month total, while ASX reinstatement remains conditional.
Victor Sage
Victor Sage
28 Oct 2026
Richmond Vanadium Technology has submitted a revised preliminary environmental impact statement for its North Queensland vanadium project, setting up a possible public review in early 2027. The company ended September with A$3.49 million in cash and estimated funding for 2.6 quarters.
Maxwell Dee
Maxwell Dee
28 Oct 2026
EQ Resources has opened FY2027 with record revenue, EBITDA, profit and operating cashflow as tungsten production climbed 81% quarter-on-quarter. The company has also set its first full-year production, cost and capital expenditure targets, while expansion work and a Spanish regulatory issue remain key execution tests.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Globe Metals & Mining Limited (ASX:GBE) has begun early mining at its Kanyika niobium and tantalum project in Malawi, moving from site preparation to physical excavation. The milestone comes with only 1.1 quarters of reported funding and a potential requirement for substantial additional capital.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Conrad Asia Energy has moved the US$320 million Mako gas project into full-scale fabrication after completing its 75% farm-down to Nations and securing a domestic gas sales route into Batam. The project remains fully funded, with first gas targeted for the fourth quarter of 2027, although Conrad’s cash position remains modest and further carry-loan drawdowns are expected.
Victor Sage
Victor Sage
28 Oct 2026
Nexsen is pursuing a second Group B Streptococcus device through a proposed FlashDx joint venture while upgrading StrepSure after interim clinical data shifted its US FDA submission target to early 2027. The diagnostics developer ended September with $3.56 million in cash, equivalent to about four quarters of funding at the latest operating cash-flow rate.
Ada Torres
Ada Torres
28 Oct 2026

Browse the archive

Full archive